Republicans Seek Documents, Schedule Hearing Related To FDA’s Response To Baby-Formula Shortage
House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year.
Despite Failed Phase 3 Study, FDA Staff Says Biogen’s ALS Drug May Have Clinical Benefit
FDA’s Peripheral and Central Nervous System Drugs Advisory Committee will virtually meet on Wednesday, March 22, to discuss Biogen Inc’s (NASDAQ:BIIB) ALS…
Roivant Sciences Highlights Topline Data From Atopic Dermatitis Drug In Patients As Young As 2 Years
Dermavant Sciences, a Roivant Sciences Ltd. (NASDAQ:ROIV) company, announced results from ADORING 2 Phase 3 study evaluating VTAMA (tapinarof) cream, 1% in…
ThermoGenesis Rolls Out Manufacturing Suites For Use In Early-Stage Cell, Gene Therapy, Shares Soar
ThermoGenesis Holdings Inc (NASDAQ:THMO) is rolling out a new facility in the Sacramento metro area, containing 12 class-7, ReadyStart…
Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study
Protagonist Therapeutics Inc (NASDAQ:PTGX) announced topline results from the blinded, placebo-controlled, randomized withdrawal portion of REVIVE of rusfertide for polycythemia vera,…
Why Jounce Therapeutics Stock Is Moving Higher Today?
The Board of Directors of Jounce Therapeutics Inc (NASDAQ:JNCE) confirmed that Concentra Biosciences LLC made an unsolicited and non-binding proposal to acquire 100%…
Apple Eases On Bonus & Hiring, Federal Reserve Mulls Tougher Rules After SVB Failure, Meta-Backed Undersea Cable Project Delayed By China: Today’s Top Stories
Reuters
Fed Mulling Tougher Rules For Midsize Banks After SVB Crash
Data For Pfizer’s COVID-19 Drug Shows No Possible Association With Infection Rebound
The FDA dropped in briefing document as the agency’s external advisors meet on Thursday (March 16) to discuss complete approval…
Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B
In a complaint filed in Manhattan federal court, a Detroit-based pension fund said Amgen Inc (NASDAQ:AMGN) concealed the dispute over…
Analyst Says Biogen-Eisai’s Alzheimer’s Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
Eisai Co Ltd (OTC:ESALY) and Biogen Inc (NASDAQ:BIIB) said the U.S. Department of Veteran Affairs (VA) would provide coverage of their…